Ignite Creation Date:
2024-05-06 @ 8:09 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06271057
Status:
RECRUITING
Last Update Posted:
2024-02-21
First Post:
2024-02-14
Brief Title:
Golcadomide Post-CAR T-cell in RR Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
Sponsor:
The Lymphoma Academic Research Organisation
Organization:
The Lymphoma Academic Research Organisation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Diffuse Large B-cell Lymphoma Refractory |
| Refractory Primary Mediastinal Large B-Cell Lymphoma |
| Refractory Transformed B-cell Non-Hodgkin Lymphoma |
| Refractory High Grade B-Cell Lymphoma |
Keywords:
| Name | View |
|---|---|
| eligible for CAR T-cells therapy | View |